Baxter International Inc. (BAX)

75.94
0.69 0.92
NYSE
Prev Close 75.25
Open 75.69
Day Low/High 75.32 / 75.99
52 Wk Low/High 61.05 / 78.38
Volume 451.75K
Exchange NYSE
Shares Outstanding 511.12B
Market Cap 37.99B
Div & Yield N.A. (N.A)

Latest News

Baxter To Host Webcast Of Annual Meeting Of Stockholders

Baxter To Host Webcast Of Annual Meeting Of Stockholders

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will host a webcast of its Annual Meeting of Stockholders on Tuesday, May 7, 2019 at 9 a.

Baxter Highlights Advancements In Clinical Nutrition At ASPEN Conference

Baxter Highlights Advancements In Clinical Nutrition At ASPEN Conference

Baxter International Inc. (NYSE:BAX), a global leader in clinical nutrition, today announced it will launch Clinolipid (20% Lipid Injectable Emulsion), its proprietary olive oil-based lipid emulsion, in the U.

Baxter To Host First Quarter 2019 Financial Results Conference Call For Investors

Baxter To Host First Quarter 2019 Financial Results Conference Call For Investors

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will host a conference call to discuss its first quarter 2019 financial results on Thursday, April 25, 2019, at 7:30 a.

Baxter Announces U.S. FDA Approval And Launch Of Ready-to-Use Cardiovascular Medicine Eptifibatide

Baxter Announces U.S. FDA Approval And Launch Of Ready-to-Use Cardiovascular Medicine Eptifibatide

Baxter International Inc. (NYSE:BAX), a global leader in sterile medication production and delivery, today announced the U.

Baxter Honored As A 2019 "Top Company For Executive Women" By The National Association For Female Executives

Baxter Honored As A 2019 "Top Company For Executive Women" By The National Association For Female Executives

Baxter International Inc. (NYSE:BAX), a leading global medical products company, announced today that it has been named one of the 2019 NAFE Top Companies for Executive Women by the National Association for Female Executives (NAFE).

Baxter Declares Quarterly Dividend

Baxter Declares Quarterly Dividend

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced that its Board of Directors has declared a quarterly cash dividend of $0.

Baxter To Present At The Barclays Global Healthcare Conference

Baxter To Present At The Barclays Global Healthcare Conference

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the Barclays Global Healthcare Conference in Miami, Fla.

Baxter To Present At The Raymond James 40th Annual Institutional Investors Conference

Baxter To Present At The Raymond James 40th Annual Institutional Investors Conference

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the Raymond James 40th Annual Institutional Investors Conference in Orlando, Fla.

Baxter Reports 2018 Fourth-Quarter And Full-Year Results

Baxter Reports 2018 Fourth-Quarter And Full-Year Results

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today reported results for the fourth quarter and full year ended Dec.

Baxter To Present At The 8th Annual SVB Leerink Global Healthcare Conference

Baxter To Present At The 8th Annual SVB Leerink Global Healthcare Conference

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the 8th Annual SVB Leerink Global Healthcare Conference in New York, NY on Thursday, February 28, 2019.

Baxter's Sharesource Remote Patient Management Platform Has Logged More Than 5 Million Home Peritoneal Dialysis Treatments Globally; Milestone Is Evidence That Smarter, More Effective Innovation Is Enhancing Renal Care. (Photo: Business Wire)

Baxter's Sharesource Remote Patient Management Platform Has Logged More Than 5 Million Home Peritoneal Dialysis Treatments Globally; Milestone Is Evidence That Smarter, More Effective Innovation Is Enhancing Renal Care. (Photo: Business Wire)

Baxter International Inc. (NYSE:BAX), a global innovator in renal care, announced the Sharesource remote patient management platform has performed more than 5 million home peritoneal dialysis (PD) treatments globally.

Baxter Has Started The U.S. Clinical Trial For Its Latest Peritoneal Dialysis Technology Designed To Generate Solution On Demand In Homes.

Baxter Has Started The U.S. Clinical Trial For Its Latest Peritoneal Dialysis Technology Designed To Generate Solution On Demand In Homes.

Baxter International Inc. (NYSE:BAX), a global innovator in renal care, announced today that the first patients have been enrolled in a U.

Baxter To Host Fourth Quarter 2018 Financial Results Conference Call For Investors

Baxter To Host Fourth Quarter 2018 Financial Results Conference Call For Investors

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will host a conference call to discuss its fourth quarter 2018 financial results on Thursday, January 31, 2019, at 7:30 a.

Baxter Launches Curved Applicator For Floseal, Expanding Use Of Leading Hemostat During ENT Procedures

Baxter Launches Curved Applicator For Floseal, Expanding Use Of Leading Hemostat During ENT Procedures

Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced the introduction of the Disposable Curved Applicator, which enhances the delivery experience of its Floseal Hemostatic Matrix product line for...

Baxter Supports New EFCNI Standards In Newborn Care In Raising Awareness Of Risks From Malnutrition

Baxter Supports New EFCNI Standards In Newborn Care In Raising Awareness Of Risks From Malnutrition

Baxter International Inc. (NYSE:BAX), a global leader in clinical nutrition, is collaborating with the European Foundation for the Care of Newborn Infants (EFCNI) to raise awareness for the new EFCNI standards that address the disparities in newborn care...

Baxter Appoints Patricia Morrison And Amy Wendell To Its Board

Baxter Appoints Patricia Morrison And Amy Wendell To Its Board

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced it has appointed Patricia B.

Baxter To Present At The 37th Annual J.P. Morgan Healthcare Conference

Baxter To Present At The 37th Annual J.P. Morgan Healthcare Conference

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the 37th Annual J.

Baxter Unveils New Products At The ASMBS - Obesity Week Meeting To Help Surgeons Overcome Challenges During Bariatric Surgery

Baxter Unveils New Products At The ASMBS - Obesity Week Meeting To Help Surgeons Overcome Challenges During Bariatric Surgery

Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, revealed its Peri-Strips Dry with Veritas (PSDV) Circular Staple Line Reinforcement with Secure Grip technology, the latest evolution in a product portfolio that has...

Baxter Declares Quarterly Dividend And Announces Expanded Share Repurchase Authorization

Baxter Declares Quarterly Dividend And Announces Expanded Share Repurchase Authorization

Baxter International Inc. (NYSE:BAX), a leading global medical products company, announced today a quarterly cash dividend and an expanded authorization for its share repurchase program.

Baxter Highlights Data At ISPOR Europe 2018 On Clinical And Economic Benefits When Addressing Malnutrition, Intraoperative Bleeding

Baxter Highlights Data At ISPOR Europe 2018 On Clinical And Economic Benefits When Addressing Malnutrition, Intraoperative Bleeding

Baxter International Inc. (NYSE:BAX), a leading global medical products company, is presenting four health economics and outcomes research (HEOR) analyses this week at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Europe...

Baxter Introduces New Tisseel Prima Syringe At 2018 American Association Of Gynecologic Laparoscopists Meeting

Baxter Introduces New Tisseel Prima Syringe At 2018 American Association Of Gynecologic Laparoscopists Meeting

Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today unveiled the latest design enhancements for its fibrin sealant product, the Tisseel Prima syringe, at the 2018 American Association of Gynecologic Laparoscopists...

Baxter To Present At Citi's 2018 Global Healthcare Conference

Baxter To Present At Citi's 2018 Global Healthcare Conference

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at Citi's 2018 Global Healthcare Conference on Thursday, December 6, 2018, in New York.

Baxter International Breaks Its February/April Lows: Now What?

Baxter International Breaks Its February/April Lows: Now What?

BAX is now in a weak technical position.

A One-Two Punch to the Bears: Cramer's 'Mad Money' Recap (Thursday 11/1/18)

A One-Two Punch to the Bears: Cramer's 'Mad Money' Recap (Thursday 11/1/18)

Jim Cramer's been saying that that if the Fed or the president blink in their wars against inflation and China you could have an up day. That's what we got.

Jim Cramer: Even Safe-Haven Big-Cap Drug Stocks Are Now Broken

Jim Cramer: Even Safe-Haven Big-Cap Drug Stocks Are Now Broken

Once the safest stocks in the book, the big-cap drug companies are now toxic.

Baxter Reports Third-Quarter 2018 Results And Updates Financial Outlook For Full-Year 2018

Baxter Reports Third-Quarter 2018 Results And Updates Financial Outlook For Full-Year 2018

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today reported results for the third quarter of 2018 and updated its full-year 2018 financial outlook.

Baxter Highlights Fifteen Studies Presented At ASN: Kidney Week 2018 On HDx Therapy Enabled By Theranova And Sharesource Remote Patient Management, Adding To Significantly Growing Global Clinical Evidence (Photo: Business Wire)

Baxter Highlights Fifteen Studies Presented At ASN: Kidney Week 2018 On HDx Therapy Enabled By Theranova And Sharesource Remote Patient Management, Adding To Significantly Growing Global Clinical Evidence (Photo: Business Wire)

Baxter International Inc. (NYSE:BAX), a global innovator in renal care, highlighted findings from HDx (expanded hemodialysis) and peritoneal dialysis (PD) studies presented at the American Society of Nephrology (ASN): Kidney Week, Oct.

TheStreet Quant Rating: A+ (Buy)